This chapter explores the potential of the weight loss drug market and the production challenges faced by Novo Nordisk and Eli Lilly, including Novo Nordisk's acquisition strategy to expand production capacity. It also draws parallels between this production race and Tesla's challenges, and briefly mentions Chris Dixon's book on the next era of the internet.